Initiating a CGRP-targeted therapy – practical aspects of care

AUS

$0

free

RACGP CPD Program

15 min

Neurology

2 Credits

Course Description

Migraine is a neurological condition that affects an estimated 4.9 million Australians. It is associated with significant wellbeing costs for those living with migraine disease as well as a total estimated economic cost in Australia of $35.7 billion in 2018.

Despite this substantial impact, migraine remains under-diagnosed and under-treated in Australia.

The fourth of this 4-part series revisits the case study of a typical patient presenting with worsening migraines and examines practical aspects of initiating a CGRP-targeted therapy.

Participants must read all 4 issues and then complete the questions on Issue 4 to claim RACGP CPD points.


This program is supported by an independent educational grant provided by Eli Lilly.

Course Details

Expiry Date: 2021-12-07

Professions: Physician

Faculty

Dr Bronwyn Jenkins, Neurologist, FRACP, BMed

Dr Christina Sun Edelstein, Neurologist, FRACP, MD

Dr Simon Cowap, General Practitioner

Accreditation

This Active Learning Module has been approved by RACGP CPD Program for 2 CPD points.

Activity no. 226888

Members are able to claim CPD activity points for 2 points through ‘Quick log’ on their RACGP CPD Dashboard.

Learning Objective(s)

On completion of this clinical brief, GPs will be able to: 

  • Define migraine as a neurological disorder and understand its clinical phases
  • Recognise the burden of migraine including its significant impact on quality of life 
  • Demonstrate how the introduction of CGRP inhibitors has changed the treatment paradigm in migraine prevention
  • Identify patients who could benefit from timely introduction of preventive therapy, including CGRP inhibitors
  • Confidently initiate preventative treatments as an effective strategy in migraine management 
  • Understand the place of CRGP inhibitors in migraine prevention strategies
  • Develop strategies for ensuring optimal outcomes with preventive therapy including monitoring, counseling patients on administration and adherence, and providing self-care advice